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Abstract
Hypothesis—Accessing the phase inversion temperature by microwave heating may enable the 
rapid synthesis of small lipid nanoparticles.
Experiments—Nanoparticle formulations consisted of surfactants Brij 78 and Vitamin E TPGS, 
and trilaurin, trimyristin, or miglyol 812 as nanoparticle lipid cores. Each formulation was placed 
in water and heated by microwave irradiation at temperatures ranging from 65 °C to 245 °C. We 
observed a phase inversion temperature (PIT) for these formulations based on a dramatic decrease 
in particle Z-average diameters. Subsequently, nanoparticles were manufactured above and below 
the PIT and studied for (a) stability toward dilution, (b) stability over time, (c) fabrication as a 
function of reaction time, and (d) transmittance of lipid nanoparticle dispersions.
Findings—Lipid-based nanoparticles with distinct sizes down to 20–30 nm and low 
polydispersity could be attained by a simple, one-pot microwave synthesis. This was carried out by 
accessing the phase inversion temperature using microwave heating. Nanoparticles could be 
synthesized in just one minute and select compositions demonstrated high stability. The notable 
stability of these particles may be explained by the combination of van der Waals interactions and 
steric repulsion. 20–30 nm nanoparticles were found to be optically transparent.
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1. Introduction
The unique and wide-ranging properties of nanoparticles (NPs) have advanced numerous 
technologies. Ideal nanoparticle properties include low polydispersity for homogeneity, 
optical transparency for aesthetics, simple fabrication for scale-up, and physical stability for 
long-term application[1–3]. In addition, physical stability toward dilution is a critical 
property in drug delivery and cosmetics where NPs encounter notable changes in 
concentration. Nanoparticle size is a key property in determining behavior. For example, in 
sensing and analytical detection[4], [5], the light absorption and scattering properties of 
nanoparticles depend on size. Moreover, in nano-therapeutics, the size of NPs can influence 
blood circulation time, tissue targeting, drug release rate, and corresponding efficacy [6–9]. 
In cosmetics, skin hydration and absorption of active ingredients is influenced by 
nanoparticle size[10]. For food products, the color and appearance are crucial characteristics 
to consumers and depend on NP size[11], [12]. The importance of nanoparticle size can also 
be noted for catalysis[13, 14], pesticides[15, 16], and energy[17], [18] industries.
Many industries utilize lipid-based nanoparticles due to their biocompatibility, scalability, 
cheap raw materials, tunable cargo release, and the use of aqueous solvents in synthesis. 
Notable lipid-based nanoparticles include nanoemulsions and solid-lipid nanoparticles 
(SLNs). Lipid-based NPs consist of a core, liquid or solid, that is stabilized by surfactants. 
This yields stable dispersions with small sizes, large surface areas, and distinct core 
morphologies. Lipid NPs are typically made by high pressure homogenization, high shear 
homogenization, and ultrasonication[10], [19]. More recently, solid lipid nanoparticles 
(SLNs) have been prepared by a microemulsion-based technique using a Taguchi model of 
experimental design[20]. A follow-up study on this work involved the fabrication of these 
SLNs with microwave heating[21]. Compared to conventional heating, microwave heating 
yielded lower polydispersity particles with smaller sizes and a core-shell structure in a 
possible lamellar arrangement[22].
Microwave irradiation has also been utilized to synthesize nanoemulsions. For example, 
surfactant free emulsion polymerization was carried out for poly(methyl methacrylate) 
particles using microwave methodology[23]. Sub-50 nm crosslinked particles were obtained 
in a one-step process with good polydispersity. Another example involves the microwave-
assisted synthesis of poly(ethylene glycol)-block-poly(styrene) emulsion nanoparticles, 
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which assumed smaller size and lower polydispersity when compared to conventional 
heating[24].
Smaller nanoparticles with lower polydispersity indices may be obtained by microwave 
synthesis on account of efficient localized heating and lower temperature gradients 
throughout the sample. Furthermore, microwave synthesis generally provides increased rates 
of reaction and product yields due to fast, homogeneous, and efficient dielectric heating[25]. 
In conventional heating, the vessel walls are heated first and then the heat diffuses into the 
reaction mixture. Conversely, microwave heating allows for higher temperatures to be 
reached rapidly by homogeneous heating of the entire reaction volume.
Here, we harness the advantages of microwave synthesis to influence the size of 
nanoparticles with a lipid-triglyceride core, both liquid and solid. Specifically, microwave 
heating was used to reduce lipid NP size. Small nanoparticles were tested for stability and 
scalability. We found an approach that is scalable and offers rapid synthesis of nanoparticles 
using biocompatible excipients. Furthermore, this approach provides a one-pot synthesis 
yielding purified nanoparticles directly from the microwave reactor. Nanoparticles with a 
lipid-triglyceride core, both liquid and solid, were rapidly fabricated using microwave 
heating. These nanoparticles had (1) small sizes depending on microwave conditions, (2) 
low polydispersity, (3) physical stability, and (4) optical transparency.
2. Experimental section
2.1 Materials
Polyoxyl 20-stearyl ether (Brij 78) was obtained from Uniqema (Wilmington, DE), d-alpha 
tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS) was acquired from 
Eastman Chemicals (Kingsport, TN), and Miglyol 812 was purchased from Sasol (Witten, 
Germany) Trilaurin and trimyristin were purchased from Sigma Aldrich. Solvents were 
obtained from Thermo Fisher Scientific, Inc. Accessories for particle fabrication and 
analysis were obtained from Biotage and Thermo Fisher Scientific, Inc. The magnetic stir 
bars were made of ferrite and coated with poly(tetrafluoroethylene), and had a V-shape to fit 
the microwave vials. NP fabrication occurred in a Biotage® Initiator Classic microwave 
synthesizer. Dynamic light scattering occurred in a Zetasizer Nano ZS Particle Analyzer 
(Malvern Instruments, Inc.). % Transmittance was calculated from measurements on a 
SpectraMax M5 Plate Reader (Molecular Devices).
2.2 Synthesis of lipid-based particles
The formulation of nanoparticles was selected based on previous work[26, 27]. In a typical 
experiment, Brij 78, Vitamin E TPGS, and trilaurin were dissolved separately in chloroform 
to make stock solutions in 1.5 mL Eppendorf tubes. Aliquots were taken from the stock 
solutions containing 1.75 mg of Brij 78, 0.75 mg of Vitamin E TPGS, and 1.25 mg of 
trilaurin, which were added to a 0.5-2.0 mL microwave reaction vial and mixed by pipetting. 
The solvent was evaporated, yielding a film of the components. Filtered, deionized water 
(0.5 mL) was then added to the film to provide a 7.5 mg/mL concentration. The vial was 
charged with a magnetic stir bar and sealed with a microwave cap. The vial was then loaded 
Dunn et al. Page 3
J Colloid Interface Sci. Author manuscript; available in PMC 2018 February 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
into the microwave synthesizer for a given time at a particular temperature using the very 
high absorption setting and fixed hold time (countdown starts after reaching the target 
temperature). All particles were synthesized in triplicate.
2.3 Characterization of lipid-based particles
The size of lipid-based particles was evaluated using Zetasizer Nano ZS Particle Analyzer 
(Malvern Instruments, Inc.). For the analysis of particles synthesized as a function of 
temperature and time, 0.5 mL of the particle dispersion in the microwave vial was directly 
aliquoted into a disposable microcuvette. Three measurements were taken for each particle 
sample using automatic measurement duration and 173° backscatter general purpose 
analysis model at 25 °C in water. We collected Dz, PDI, PDI width, and ζ-potential. The ζ-
potential was measured on samples in 10 mM NaCl using a clear disposable zeta cell with 
automatic duration time, three measurements, and the Smoluchowski approximation.
2.4 Characterization of particle dilution
For the dilution studies, 0.5 mL of particles was diluted from 7.5 mg/mL to 2.5 mg/mL with 
water for the initial 3-fold dilution measurement. 100 µL of this initial solution was added to 
900 µL water in a disposal cuvette to provide 30-fold dilution. For 150-fold dilution, 200 µL 
of the initial solution was added to 800 µL water. This was repeated out to a maximum of 
30,000-fold dilution. The absolute percent change was determined for each particle based on 
the Z-average diameter at a particular dilution factor and the initial Z-average diameter at 7.5 
mg/mL. The stability of nanoparticles was assessed from three different particle batches. Δ10 
was calculated using one phase decay exponential fitting using GraphPad Prism software.
2.5 Characterization of stability over time
For the stability of particles over time, size measurements were taken after 1, 2, 3, and 4 
weeks from the initial measurement using three different particle batches. Particles were 
stored at room temperature (23°C) at 7.5 mg/mL particle concentration in 1.5 mL Eppendorf 
tubes and dispensed into a disposable microcuvette for size analysis at each time point.
2.6 Characterization of particle transmittance
100 µL of 2.5 mg/mL particle dispersion was dispensed into 96-well clear-bottom plates. 
Absorbance measurements were taken every 10 nm from 400 nm to 700 nm using 
SpectraMax M5 Plate Reader (Molecular Devices). Three different batches of each unique 
NP type were measured and averaged. Percent transmittance was calculated from 
absorbance using the following equation: A = 2 – log(%T) where A is the absorbance and 
%T is the percent transmittance. The average percent transmittance of each sample was 
presented by normalizing with water as the reference background.
3. Results and Discussion
3.1 Synthesis and characterization of lipid nanoparticles
To start we leveraged a nanoparticle composition previously reported[26, 27] due to its 
exceptional stability and simple fabrication. Furthermore, this nanoparticle composition was 
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scalable, efficacious in cancer treatment, and passed the National Cancer Institute’s assay 
cascade [28–30]. Specifically, the lipid particle formulations were comprised of 
poly(ethylene glycol) surfactants (Vitamin E TPGS and Brij 78) and a lipid core. We 
selected the following three triglyceride lipids with unique alkyl chain lengths and different 
morphologies: miglyol 812 (liquid, Tm = −12.5 °C), trilaurin (solid, Tm = 46.5 °C), and 
trimyristin (solid, Tm = 56–57 °C). Nanoparticles were designated by the composition based 
on Brij 78, TPGS, and the lipid core. For example, a nanoparticle formulation consisting of 
Brij 78, vitamin E TPGS, and Miglyol would be denoted as BTM. Conventional heating of 
the BTM formulation at 65 °C for 30 minutes yielded 180-200 nm nanoparticles, which 
showed long circulation; however, these NPs may be too large to evade the 
reticuloendothelial system.
The three particle formulations investigated herein were abbreviated as BTM, BTL, and 
BTMy for Miglyol 812, triLaurin, and triMyristin cores, respectively. Lipid particles were 
synthesized via a one-pot approach using microwave irradiation. To determine the effect of 
reaction temperature on particle size, particles were synthesized at temperatures ranging 
from 65 °C to 245 °C in 20 °C increments (Figure S1) for 30 minutes. In general, at low 
(<125 °C) and high temperatures (>205 °C) nanoparticle size was large, while at 
intermediate temperatures, small nanoparticle sizes were accessible. This behavior may be 
explained by the phase inversion temperature (PIT) concept [31–34]. Phase inversion 
involves positive or negative spontaneous curvature changes in the surfactant during the 
emulsification process. At the PIT, the spontaneous curvature of the surfactant is zero, 
interfacial tension is low, and emulsion droplets are generally small.
For BTM and BTL formulations, microwave synthesis at 65 °C yielded nanoparticles sizes 
(Dz) of 190 nm and 280 nm, respectively (Figure 1b), with PDIs below 0.3. At 125 °C with 
microwave heating, small nanoparticles were obtained with Dz of 26 nm and 35 nm for 
BTM and BTL. The BTMy formulation showed no change in size regardless of temperature, 
and small nanoparticles could not be obtained at any temperature. The ζ-potential of BTM, 
BTL, and BTMy NPs synthesized under these conditions ranged from -3 mV to -5 mV 
(Table S2).
The inability of BTMy to reach small sizes may be attributed to lower affinity of the 
surfactant toward trimyristin due to its increased molecular weight and longer alkyl chains. 
The lower affinity of the surfactant toward the lipid combined with its larger size may 
influence the structures encountered at the PIT, hindering formation of small droplets. It 
could be possible to access 30 nm nanoparticles using more surfactant; however, this would 
drastically change the composition already established[22]. Given that we did not obtain 
smaller NP sizes with BTMy, we focused only on BTM and BTL NPs for subsequent 
experiments.
3.2 Stability of lipid nanoparticles toward dilution
The stability of each lipid nanoparticle was evaluated by monitoring the NP size in 
increasingly dilute conditions (Figure 2). If the NP size increased by 10% of the original size 
we considered the system unstable. We called this number delta-10 (Δ10). An estimated 
dilution factor and particle concentration was calculated at the delta-10 (Table 1). The higher 
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the dilution factor, the more stable the NP. Similarly, the lower the particle concentration, the 
more stable the NP. These dilution stability assays are relevant in cosmetics and drug 
delivery applications where particles are subjected to large changes in concentration. For 
example, in drug-delivery, intravenous injection of nanoparticles will be subjected to an 
instant dilution of 10-100x immediately after injection. Therefore, the stability towards this 
degree of dilution is of utmost importance. BTM and BTL NPs prepared at 65 °C and 
125 °C were analyzed for dilution stability.
The nanoparticles are designated by preparation temperature. For example, BTL65 
represents trilaurin-based NPs fabricated at 65 °C. Consistently, we found that NPs prepared 
at 65 °C were more stable than NPs fabricated at 125 °C. For instance, the Δ10 dilution 
factor for BTM65 (2016x) was roughly 12 times higher than that of BTM125 (162x). 
Similarly, the Δ10 dilution factor for BTL65 was 27 times higher than that of BTL125. BTL65 
showed the greatest stability, which may be due to it having the largest Z-average diameter. 
In these studies, smaller particles were found to be less stable toward dilution than larger 
nanoparticles, which may be attributed to the difference in surface area to volume ratios. 
However, these small nanoparticles were still very stable and could withstand a 100-fold 
dilution. The stability of these nanoparticles may be attributed to van der Waals attraction 
and steric repulsion, which arises with nonionic surfactants[32]. The size of the diluted 
nanoparticles may increase over time due to surfactant desorption, Oswald ripening, and 
coalescence. Long-term stability of diluted nanoparticles may be realized by adding glycerol 
or ionic surfactants as noted in literature [35, 36].
3.3 Stability of lipid nanoparticles over time
In addition to the stability of the nanoparticles toward dilution, the stability of lipid 
nanoparticles over time was investigated. This was completed by monitoring their size over 
four weeks at one week intervals (Figure 3). We observed that BTL NPs showed smaller 
changes in size than BTM NPs over 4 weeks. For example, BTM125 increased 13 nm while 
BTL125 changed less than 1 nm after 4 weeks. Similarly, BTM65 NPs changed 21 nm in 
diameter while BTL65 changed 3 nm after 4 weeks. Statistical analysis was performed on 
lipid nanoparticles comparing the initial measurement with each week time point. The 
changes in particle size were significant (p<0.05) for both BTM NPs using a t-test. 
Conversely, BTL particles did not show significant fluctuations in size based on a similar t-
test. Solid core NPs were more stable over time than liquid core NPs, which may be 
attributed to the different lipid morphologies.
3.4 Synthesis of lipid nanoparticles as a function of time
To facilitate rapid production of these lipid-based particles for potential applications, the 
effect of reaction time on particle size was studied. Conventional approaches to fabricate 
lipid-based nanoparticles require 30 min[26, 27]. Herein, reaction times of 30 min, 10 min, 5 
min, and 1 min were utilized at 65 °C and 125 °C (Figure 4). Short reaction times facilitate 
scale-up, which is important for industrial applications. In just 1 minute, and for the first 
time, BTM nanoparticles could be synthesized at 65 °C and 125 °C to provide sub-30 nm 
nanoparticles. Across all reaction times, small BTM125 NPs were observed with diameters 
less than 32 nm and were statistically similar. BTMs responded particularly well to high 
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temperatures at short times. The microwave-assisted synthesis of both large and small BTM 
nanoparticles demonstrates potential for rapid scale-up.
Larger BTL particles could be synthesized in 1 minute at 65 °C with statistically similar 
sizes down to 5 min. Conversely, smaller BTL nanoparticles could not be synthesized at 
short times at 125 °C, and still required 30 minutes of microwave heating. The difference in 
particle size versus microwave time is attributed to core morphology. Specifically, longer 
time is required to melt the solid trilaurin lipid and reach equilibrium with the surfactants to 
access the PIT. Once in a nanoemulsion state with the lipid melted, it is possible to form 
small BTL nanodroplets. This small nanoparticle state in the PIT is maintained post-
fabrication since the microwave synthesizer rapidly cools the reaction after completion and 
solidifies the trilaurin lipid core.
The transparency of lipid-based nanoparticles was studied over the visible wavelength 
spectrum (Figure 5). The transparency of nanoparticles finds importance in a variety of 
technologies such as coatings and cosmetics for aesthetic characteristics. For example, 
sunscreen formulations favor transparent nanoparticles, antioxidants, and UV absorbers 
(filters[37]). This lipid-based nanoparticle formulation utilizes vitamin E, which is both an 
antioxidant and UV absorber, making these nanoparticles ideal for sunscreens and other 
cosmetics.
3.5 Transmittance of lipid nanoparticles
Optical transparency from 400-700 nm was observed for small nanoparticles fabricated at 
125 °C (BTM125 and BTL125). Distinct transmittance profiles were observed for larger 
particles with the percent transmittance (%T) ranging from 35% to 86%. At 500 nm, the %T 
of BTM65 was 1.5 times higher than that of BTL65 (Table 2). This is attributed to the larger 
size of BTL65 NPs, which will absorb more light. Distinct transmittance profiles, including 
optical transparency, were provided for lipid-based nanoparticles by this microwave-assisted 
synthetic approach.
4. Conclusions
Through our investigations we were able to control the preparation of lipid-based 
nanoparticles using microwave heating, and fabricate small nanoparticles in unprecedented 
reaction times. Previously, microwave heating has been utilized to prepare lipid-based 
nanoparticles with diameters between 100 nm to 300 nm in 10 minutes [21, 22, 38]. 
Furthermore, the phase inversion temperature (PIT) method has been reported [31–34] to 
show nanoparticle sizes below 100 nm [39–42]. We selected a formulation that has been 
used to prepare ~200 nm nanoparticles with the ability to target tumors, deliver 
chemotherapeutic drugs in vivoand overcome multidrug resistance [26–30]. For the first 
time, we have demonstrated the feasibility in accessing the PIT method by microwave 
heating to yield sub-30 nm nanoparticles. Moreover, these nanoparticles are physically 
stable, optically transparent, and can be fabricated in 1 minute. These improvements are not 
possible using conventional thermal heating [27]. To the best of our knowledge, this is the 
first demonstration of 20–30 nm lipid nanoparticles fabricated by microwave irradiation 
using this formulation. Future work utilizing the PIT-microwave heating approach may be 
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applied to a range of colloidal systems involving different surfactants and lipids to access 
smaller nanoparticle sizes in faster times for a variety of applications. Specifically, the rapid 
synthesis of 20–30 nm nanoparticles presented herein may allow for enhanced tumor 
targeting, drug delivery efficacy, and scalability toward potential clinical application. Tumor 
targeting and drug delivery efficacy may be enhanced by using 20–30 nm NPs as this size 
range has been shown to have the longest blood circulation half life and highest tumor 
accumulation[43].
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Abbreviations
NPs Nanoparticles
Tm melting temperature
BTM, BTL, or BTMy Brij 78, vitamin E TPGS, and Miglyol 812, triLaurin, or 
triMyristin
delta-10 (Δ10) the point at which particle size increased by 10%
BTM65/125 BTM NPs fabricated at 65 °C or 125 °C;
BTL65/125 BTL NPs fabricated at 65 °C or 125 °C;
Dz Z-average diameter
PDI polydispersity index
n.s. not significant
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Figure 1. 
(a) Schematic of lipid nanoparticles with different sizes synthesized at microwave 
temperatures Ta or Tb. (b) Z-average diameter (Dz) of BTM, BTL, and BTMy nanoparticles 
synthesized at 65 °C and 125 °C for 30 min. Error bars represent ± the standard deviation 
over 3 measurements.
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Figure 2. 
(a) Absolute percent change of Z-average diameter and (b) size stability of BTM and BTL 
NPs synthesized at 65 °C or 125 °C for 30 min as a function of dilution. Error bars represent 
± the standard deviation over 3 measurements.
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Figure 3. 
Stability of BTM and BTL lipid nanoparticles synthesized at 65 °C or 125 °C for 30 min 
over four weeks in one week intervals. Error bars represent ± the standard deviation over 3 
measurements.
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Figure 4. 
Z-average diameter of lipid particles as a function of reaction time. Error bars represent ± 
the standard deviation over 3 measurements. #Some samples consisted of more than one 
peak in dynamic light scattering.
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Figure 5. 
Transmittance of lipid nanoparticles synthesized at 65 °C or 125 °C for 30 min over the 
visible wavelength spectrum. Small nanoparticles are optically transparent while large 
particles exhibit distinct transmittance profiles.
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Table 1
Dilution factor and concentration at the Δ10 of each nanoparticle with Z-average diameter (Dz) ± the standard 
deviation over 3 measurements.
Particle Dilution factor Concentration (µg/mL) Dz
BTM65 2016x 1.2 189.5 ± 5.7
BTM125 162x 15.4 26.1 ± 1.6
BTL65 4404x 0.6 280.0 ± 16.3
BTL125 159x 15.7 34.6 ± 12.9
J Colloid Interface Sci. Author manuscript; available in PMC 2018 February 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Dunn et al. Page 17
Table 2
Percent transmittance (%T) of lipid nanoparticles at 500 nm ± the standard deviation over 3 measurements.
Particle %T at 500 nm
BTM125 99.4 ± 0.2
BTM65 75.9 ± 8.1
BTL125 99.2 ± 0.2
BTL65 49.4 ± 2.8
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